Satofuka, Hiroyuki
Wang, Yayan
Tanaka, Hiroshi
Hiramatsu, Kei
Morimoto, Kayoko
Takayama, Haruka
Tu, Haochen
Qiao, Yu
Ito, Satoru
Gao, Xu
Oshimura, Mitsuo
Kazuki, Yasuhiro
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP24K11652)
JST CREST (JPMJCR18S4)
Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences (No.21-101)
Japan Agency for Medical Research and Development (JP21am0101124, JP24ama121046, JP24gm1610006, JP24gm0010010, JP23am0401002, JP24gm1810008)
Article History
Received: 27 February 2024
Accepted: 20 September 2024
First Online: 4 October 2024
Declarations
:
: M.O. is a CEO, employee, and shareholder of Trans Chromosomics, Inc., and H.Tanaka, K.H., K.M., and H. Takayama are employees of Trans Chromosomics, Inc. S.I. is a CEO, employee, and shareholder of Purotech Bio Inc. The remaining authors declare no competing interests.